Innovation for Health - 15-16 April 2021
Innovation for Health - Shaping the future of healthcare

Jan-Frens van Giessel

Holland Capital
Jan-Frens van Giessel

Partner Healthcare, Holland Capital
Jan-Frens is partner at Holland Capital since early 2018. At Holland Capital he is focusing on early stage investments in the field of medical devices, diagnostics and digital health. To realize a long-term impact on healthcare, a combination of technology, knowledge of healthcare processes, implementation power and, above all, perseverance is crucial. He invest in entrepreneurs who have shown that they have this combination of skills and who are eager to take the next step with Holland Capital to scale their business.
As investor and board member he is actively involved in portfolio companies like LivAssured (detection of epileptic attacks), CytoSmart (live cell imaging using AI and cloud computing), and Prolira (delirium detection).
He has been working with start-ups and breakthrough healthcare innovations as an advisor and investor for more than ten years. Before joining Holland Capital, Jan-Frens has been working as a senior investment manager at OostNL Capital. He has closed over 25 transactions and has been actively involved with successful companies like Mimetas (organ-on-a-chip), Xenikos (innovative immunotherapy) and Screenpoint Medical (Artificial Intelligence in Radiology). He also worked as director at the Netherlands Foreign Investment Agency in Boston (USA), the Centre for Medical Imaging at the University of Twente, and Technopolis Group. He holds an MSc in Science & Innovation Management from the University of Utrecht.

Holland Capital

About Holland Capital
Over the past 35 years, Holland Capital has invested in more than 130 Dutch companies in a responsible and successful manner. With a clear investment strategy, Holland Venture is active in the growth markets of both healthcare and technology. The experienced and involved investment team knows what entrepreneurship is like. With the joint goal of achieving growth, Holland Capital strives for an open, sustainable and professional relationship with the management teams of the companies in which we invest. Holland Venture is supported by a broad network of successful healthcare and technology entrepreneurs and experts.

Sponsors & Partners 2021
Host sponsor
Erasmus MC
Host sponsor
Gemeente Rotterdam
Host sponsor
Life Sciences & Health 010
Main Virtual Conference sponsor
Silver sponsor
Programme Sponsor AI
Award sponsor
AXON Lawyers
Powered by
Hyphen Projects
© 2020 Innovation for Health
Hyphen Projects uses cookies to remember certain preferences.
By continuing to use this site, you consent to our use of cookies. For more information, read: